Indian drug regulators say Gennova's COVID-19 vaccine safe in early trials

 Indian pharmaceutical firm Gennova Biopharmaceuticals' mRNA-based COVID-19 vaccine was found to be safe and effective in an early-stage study, the country's drug regulator said https://pib.gov.in/PressReleseDetail.aspx?PRID=1748520 on Tuesday.

Health authorities have allowed the company to conduct further studies to test the vaccine's efficacy

https://www.marketscreener.com/news/latest/Indian-drug-regulators-say-Gennova-s-COVID-19-vaccine-safe-in-early-trials--36232695/.